Report Highlights
The global proton therapy market for cancer reached $671.6 million in 2019 and should reach $1.2 billion by 2024, at a compound annual growth rate (CAGR) of 13.1% for the period of 2019-2024.
Report Includes
- 55 data tables and 25 additional tables
- A comprehensive overview of the global markets for proton therapy or proton beam therapy (PBT) in cancer treatment
- Analyses of global market trends with data from 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024
- Coverage of historical data; effectiveness, clinical benefits and side effects (for treating malignancies) of proton technology; and key role plays across various cancers
- Retrospective study outlining difference between proton-based therapy and conventional intensity modulated radiation therapy (IMRT), cost effectiveness for specific patients such as children, and clinical advances in hematology and oncology
- Assessment of recent breakthroughs, current R&D activities, rapid technological advances in PBT, expanding utilization of image-guided proton therapy, and latest trends related to this field of clinical research
- Patent review and new developments in PBT technologies
- Company profiles of leading market participants within the industry, including Elekta Instrument AB, Hitachi, Ltd., Mevion Medical Systems, Inc., Pronova Solutions, Llc, Protom International, Raysearch Laboratories Ab and Varian Medical Systems, Inc.
Report Scope
This report provides a comprehensive analysis of the proton therapy market in global context, including market forecasts and sales through 2024. The report analyzes the market by segmenting it into the various types of room types (single-room and multi-room). The end-user markets focus on hospitals, proton therapy centers and others. This study surveys the proton therapy market according to various types of cancers (by application), i.e., pediatric cancers, skull base treatment, central nervous system, head and neck cancer, prostate cancer, sarcomas, lung cancer and others. The proton therapy market is also assessed by geographic region including North America, Europe and emerging markets. Emerging markets includes countries in Africa, Asia and South America.
This report details new developments and patents boosting the growth of this market in the global context. A list of leading proton therapy centers, their locations and other details is also provided.
This report also provides comprehensive profiles of market players in the industry. The industry structure chapter focuses on the changing market trends, leading vendors, their market shares and product offerings. This chapter also covers mergers and acquisitions and any other collaborations or partnerships that happened during the forecast period and which are expected to shape the industry.
Factors such as strengths, weaknesses, threats and opportunities that are expected to play a role in the proton therapy market are evaluated in detail.
Excluded from this report are the traditional radiation therapy equipment suppliers. The carbon ion therapy is still a very small market and is thus not included with proton therapy.
Analyst Credentials
Dr. Kamna Jhamb has more than 13 years of research experience, of which more than four years have been devoted to market research. Before entering the field of market research, she worked as a Research Assistant in Lawrence Berkeley National Lab, CA. With a Ph.D. in Microbial Technology, she has vast knowledge in the areas of microbiology, protein chemistry, and molecular biology. She has several international publications in reputed journals. For BCC Research, Dr. Kamna has written reports spanning topics from healthcare, finance, to biotechnology.
Related Reports
Global Oncology Pharmaceuticals Market
The global market for oncology pharmaceuticals is estimated to increase from $196.4 billion in 2023 to reach $401.4 billion by 2029, at a compound annual growth rate (CAGR) of 12.7% from 2024 through 2029.
Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets
The global market for radiation therapy products and radiopharmaceuticals is expected to grow from $17.5 billion in 2024 and is projected to reach $31.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.3% during the forecast period of 2024 to 2029.
Diagnostics and Therapeutics for Lung Cancer: Global Markets
The global market for lung cancer grew to $21.9 billion in 2014 from $20.3 billion in 2013. The market is expected to grow at a five-year compound annual growth rate (CAGR) of 7.8% from 2014 to 2019, totaling $31.8 billion in 2019.
Recent Reports
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Infusion Pumps and Devices: Technologies and Global Markets
The global market for infusion pumps is expected to grow from $10.1 billion in 2024 and is projected to reach $14.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.7% during the forecast period of 2024 to 2029.
Top Trending Reports
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
AI in Clinical and Molecular Diagnostics Market
The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Artificial Intelligence (AI) Market: Investments vs Potential
The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.
Global Oncology Pharmaceuticals Market
The global market for oncology pharmaceuticals is estimated to increase from $196.4 billion in 2023 to reach $401.4 billion by 2029, at a compound annual growth rate (CAGR) of 12.7% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More